Equillium Inc (EQ)

0.776 +0.01 (+0.94%) USD  |  NASDAQ  |  Jan 03, 16:00
0.76 -0.02 (-2.06%) After-Hours: 20:00
More

Equillium Research and Development Expense (Annual): 37.04M for Dec. 31, 2023

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for EQ.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Matinas BioPharma Holdings Inc 14.49M
Tenon Medical Inc 3.163M
Madrigal Pharmaceuticals Inc 272.35M
Relmada Therapeutics Inc 54.81M
Spero Therapeutics Inc 51.44M